Anderman Jonathan's Form 4/A amendment
AmendedCompass Therapeutics, Inc. (CMPX) · filed Apr 30, 2026
- Accession no.
- 0001171843-26-002893
- Filed
- Apr 30, 2026
- Trade date
- Apr 29, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
- Original filed
- Apr 29, 2026
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $47.3K. It was filed 1 day after the trade.
This amendment replaces 0001171843-26-002840 (filed Apr 29, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anderman JonathanCIK 0002032625 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Common Stock | PPurchaseAcquired | +25,000 | $1.89 | +$47,250 | 196,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.